List of Qvar Redihaler drug patents

Qvar Redihaler is owned by Norton Waterford.

Qvar Redihaler contains Beclomethasone Dipropionate.

Qvar Redihaler has a total of 10 drug patents out of which 0 drug patents have expired.

Qvar Redihaler was authorised for market use on 03 August, 2017.

Qvar Redihaler is available in aerosol, metered;inhalation dosage forms.

The generics of Qvar Redihaler are possible to be released after 25 January, 2039.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8132712 NORTON WATERFORD Metered-dose inhaler
Sep, 2028

(5 years from now)

US11395889 NORTON WATERFORD Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(8 years from now)

US10695512 NORTON WATERFORD Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(8 years from now)

US10086156 NORTON WATERFORD Dose counter for inhaler and method for counting doses
May, 2031

(8 years from now)

US10022509 NORTON WATERFORD Dose counter for inhaler having a bore and shaft arrangement
May, 2031

(8 years from now)

US10022510 NORTON WATERFORD Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(8 years from now)

US8931476 NORTON WATERFORD Inhaler
Jul, 2031

(8 years from now)

US10561808 NORTON WATERFORD Dose counter for inhaler having an anti-reverse rotation actuator
Jan, 2032

(8 years from now)

US11395888 NORTON WATERFORD Inhalers and related methods
Jan, 2038

(14 years from now)

US10792447 NORTON WATERFORD Breath actuated inhaler
Jan, 2039

(15 years from now)

Drugs and Companies using BECLOMETHASONE DIPROPIONATE ingredient

Market Authorisation Date: 03 August, 2017

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic